US Pharma & Biotech Summit 2022

US Pharma & Biotech Summit 2022

Hybrid Event = In Person + Online



Find Financial Times On Social Media




Exhibit

Symposia

Workshops

Organiser

Sponsor



The US Pharma and Biotech Summit returns to New York on May 11, 2022. Industry leaders and FT journalists will discuss regional and global trends in areas such as drug discovery, clinical development and market access. How is American investment in life sciences evolving? What are the prospects for healthcare reform? How can pharma companies become more patient-centric? Join us in-person and online to learn from experts, engage with leaders and network with peers.


Themes




Driving investment

How is the American life sciences investment landscape evolving? What shifts are we seeing in M&A activity? How do investors decide where to put their money?





Accelerating innovation

What is the true potential of AI to transform R&D? To what extent is cross-industry innovation and collaboration sustainable beyond the pandemic? How can pharma workforces become more productive?






Enhancing access

How can pharma companies become more patient-centric? How could proposed US healthcare reforms affect the industry? How can cell and gene therapies be made more affordable and accessible?




Why Attend?






Understand

how pharma’s role in American healthcare is evolving through innovation in R&D, drug delivery and patient access






Discover

new approaches to drug development with the potential to transform pipelines and bring products to market faster






Connect

with some of the biggest names in the industry to learn about the latest trends, exchange ideas and build relationships


THE SUPER EARLY BIRD
IN-PERSON PASS

Get access to in-person sessions and networking drinks. Network and connect with your peers.


$699 $899



THE SUPER EARLY BIRD
DIGITAL PASS

Access to the live stream, Q&A and video on
demand.


$129 $259

Programme Available






Related articles

More events